A blaVIM-2 plasmid disseminating in extensively drug-resistant clinical Pseudomonas aeruginosa and Serratia marcescens isolates

Antimicrob Agents Chemother. 2014 Nov;58(11):7017-8. doi: 10.1128/AAC.02934-14. Epub 2014 Sep 2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Gene Transfer, Horizontal
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Plasmids
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / genetics*
  • Pseudomonas aeruginosa / isolation & purification
  • Sequence Analysis, DNA
  • Serratia Infections / drug therapy
  • Serratia Infections / microbiology
  • Serratia marcescens / drug effects*
  • Serratia marcescens / genetics*
  • Serratia marcescens / isolation & purification
  • beta-Lactamases / genetics*

Substances

  • beta-lactamase bla(vim-2)
  • beta-Lactamases

Associated data

  • GENBANK/KJ577613